UNSPSC 51201607: Hepatitis B virus vaccine

This classification denotes a vaccine for inflammation of the liver in humans caused by a member of the orthohepadnavirus genus, hepatitis b virus, which transmits (generally) by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

UNSPSC 51201607 Hepatitis B virus vaccine is a Commodity code covering immunization products procured by state health departments and related public health agencies. State and local governments use this code to acquire vaccines for public health programs, disease prevention initiatives, and immunization clinics serving populations across their jurisdictions. The work involves procurement of finished pharmaceutical products rather than manufacturing or distribution logistics; issuing bodies typically include state departments of health acting as centralized purchasing agents for statewide immunization programs.

Recent state and local activity under this code shows minimal posting volume. The Mississippi State Department of Health posted a sole source procurement notice on July 13, 2026, with an objection deadline of August 3, 2026, but the notice covers Yellow Fever Vaccine from Sanofi Pasteur, Inc., not Hepatitis B virus vaccine — indicating either a coding mismatch in the opportunity posting or a bundled vaccine procurement spanning multiple antigens under a single notice. The solicitation structure reflects public health procurement practice: the department reserved the right to conduct a competitive bid process if substantiated objections to sole source designation demonstrated alternative vendor availability. The notice provided no quantity, contract term, or estimated value. Given the single recent opportunity and its focus on a different antigen, the code shows limited recent procurement activity in the state and local space.